| 000 | 01717 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514223437.0 | ||
| 264 | 0 | _c20050927 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0268-1161 | ||
| 024 | 7 |
_a10.1093/humrep/dei018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDann, Eldad J | |
| 245 | 0 | 0 |
_aFertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. _h[electronic resource] |
| 260 |
_bHuman reproduction (Oxford, England) _cAug 2005 |
||
| 300 |
_a2247-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertility |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 |
_aOvary _xdrug effects |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aPrimary Ovarian Insufficiency _xchemically induced |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aEpelbaum, Ron | |
| 700 | 1 | _aAvivi, Irit | |
| 700 | 1 | _aBen Shahar, Menachem | |
| 700 | 1 | _aHaim, Nissim | |
| 700 | 1 | _aRowe, Jacob M | |
| 700 | 1 | _aBlumenfeld, Zeev | |
| 773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 20 _gno. 8 _gp. 2247-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/humrep/dei018 _zAvailable from publisher's website |
| 999 |
_c15486885 _d15486885 |
||